DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Election/Restrictions
Claims 66-71 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected Group II, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 9/8/26.
Specification
The disclosure is objected to because of the following informalities: Priority information should be set forth in the opening paragraph.
Appropriate correction is required.
Claim Objections
Claims 54 and 64 are objected to because of the following informalities:
In claim 54, it appears the limitation should set forth that the transducers are ‘configured to be detached’.
In claim 64, it ‘pre-selected’ should be ‘predetermined’.
Appropriate correction is required.
Claim 57 objected to under 37 CFR 1.75 as being a substantial duplicate of claim 56. When two claims in an application are duplicates or else are so close in content that they both cover the same thing, despite a slight difference in wording, it is proper after allowing one claim to object to the other as being a substantial duplicate of the allowed claim. See MPEP § 608.01(m). In particular, ‘recess’ has the same scope as ‘aperture’ given the instant specification.
Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
Claims 52, 56, 57, and 63-65 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Dougal (US Pub 2012/0046716).
Re claim 52: Dougal discloses a system for performing diagnostic or therapeutic transcranial procedures, the system comprising:
a patient-specific frame customized to specifically fit a head of a patient, such that when the patient-specific frame is placed on the head of the patient, the patient specific frame conforms to an anatomical curvature of at least a portion of the head of the patient [0056-0058, figure 6; see the head frame or helmet that is patient specific and customized to conform to the curvature of the head];
the patient-specific frame comprising a plurality of ultrasound transducer attachment interfaces such that, when each ultrasound transducer attachment interface has a respective ultrasound transducer attached thereto and the patient-specific frame is worn by the patient, the plurality of ultrasound transducers respectively attached to the plurality of ultrasound transducer attachment interfaces reside in predetermined positions and orientations relative to the head of the patient as prescribed by transducer registration data spatially registering the plurality of ultrasound transducers with a frame of reference of volumetric image data associated with the patient (figure 6; see the helmet with transducer interfaces, wherein when ultrasound transducers are positioned at these interfaces, they are in predetermined poses relative to the head; Note that the ultrasound transducers themselves are not required by the claim language);
the system further comprising a data storage medium storing the transducer registration data [0059; see the CAD package which implies a storage medium that stores a model with transducer interfaces which is considered as registration data].
Re claims 56, 57: Each ultrasound transducer attachment interface comprises a respective aperture configured to receive a respective ultrasound transducer or a respective recess configured to receive a respective ultrasound transducer of the plurality of ultrasound transducers [0034, figure 6; see the respective spacing and between transducer interfaces, each of which is an aperture or recess].
Re claims 63, 64: The plurality of ultrasound transducer attachment interfaces are supported such that the plurality of ultrasound transducers, when attached to the plurality of ultrasound transducer attachment interfaces, form a phased array and wherein the pre-selected positions and orientations of the plurality of ultrasound transducers are selected to reduce grating lobes (figure 6; see the plurality of interfaces which, when the ultrasound transducers are attached, would form a phased array and could be selected to reduce grating lobes).
Re claim 65: The frame further comprises a coupling layer, wherein the coupling layer is provided adjacent to an inner surface of the patient-specific frame such that when the frame is worn, an outer surface of the coupling layer contacts distal surfaces of the plurality of ultrasound transducers, and an inner surface of the coupling layer is configured to contact the head of the patient, thereby facilitating coupling of energy between the frame and the head of the patient (figure 6; see that when the frame is worn and when ultrasound transducers are positioned, a portion contacts the head while an outer surface contacts distal surfaces of the transducers).
Claim Rejections - 35 USC § 103
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
Claims 53-55 and 58-62 are rejected under 35 U.S.C. 103 as being unpatentable over Dougal (US Pub 2012/0046716), as applied to claim 52, in view of Hynynen et al (US Pub 2004/0210134).
Re claims 53-55, 60-62: Dougal discloses light modules for the patient specific helmet, but do not disclose the plurality of ultrasound transducers, each ultrasound transducer being removably attachable/detachable to a respective ultrasound transducer attachment interface. However, Hynynen teaches of a system for therapeutic ultrasound including a patient helmet with ultrasound transducers 16, wherein the transducers are removable and wherein all of the plurality of ultrasound transducers are detached from the plurality of ultrasound transducer attachment interfaces (figure 2, 0069, 0071; see the transducers 16 of the array 14 which are mounted in rubber, thereby being removable and detachable). Hynynen further teaches at least one ultrasound transducer of the plurality of ultrasound transducers is an ultrasound transducer module comprising a sub-array of ultrasound transducer elements, each ultrasound transducer module has a unique shape such that a given ultrasound transducer module fits uniquely with a corresponding respective ultrasound transducer attachment interface, and that a transducer of the plural transducers is an imaging transducer configured to receive reflections from a skull of the patient [0069, 0071, 0081, figure 2; see that different groups of elements correspond to subarrays, have unique shapes (i.e. spherical, planar), and are used as imaging transducers]. It would have been obvious to the skilled artisan to modify Dougal, to substitute the ultrasound transducers as taught by Hynynen, as such is achieved via simple substitution and because such is well known to be used in transcranial procedures.
Re claims 58, 59: Dougal discloses all features except control and processing hardware operably connected to the plurality of ultrasound transducers. However, Hynynen teaches of a system with control and processing hardware operably connected to the plurality of ultrasound transducers, the control and processing hardware being configured to employ the transducer registration data to control at least a portion of the ultrasound transducers to focus energy, within the head of the patient, at a pre-selected tissue region defined relative to the volumetric image data. The control and processing hardware is further configured to control a subset of the plurality of ultrasound transducers to measure, for each ultrasound transducer of the subset of ultrasound transducers, a spatial offset of a skull of the patient relative to the patient-specific frame; and employ the spatial offsets to correct a spatial registration of the plurality of ultrasound transducers relative to the pre-selected tissue region [0085, 0097, figure 2; see the control hardware coupled to the transducers that control the transducers to focus energy, wherein spatial offsets are errors that can be corrected for by adjusting transducer parameters, thereby correcting a spatial registration]. It would have been obvious to the skilled artisan to modify Dougal, to incorporate the control hardware as taught by Hynynen, in order to improve the control of the transducer for the therapy.
Double Patenting
The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969).
A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b).
The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13.
The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer.
Claims 52-65 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-16 of U.S. Patent No. 11,771,370. Although the claims at issue are not identical, they are not patentably distinct from each other because ‘370 features a system for performing diagnostic or therapeutic transcranial procedures including a patient specific frame customized to fit the head of a patient and which conforms to the head contour, a plurality of ultrasound transducers to reside in predetermined positions and orientations as prescribed by transducer registration data, control and processing hardware to employ the registration data. Further, the claims set forth a plastic support with attachment interfaces for receiving and securing the plurality of transducers and a coupling layer provided adjacent to an inner surface of the frame with an outer surface that contacts distal surfaces of the transducers. While the claims of ‘370 are different (i.e. they set forth a plastic support), it would have been obvious to conclude that the instant claims are an obvious variant.
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to MICHAEL T ROZANSKI whose telephone number is (571)272-1648. The examiner can normally be reached Mon - Fri 8:00-4:00.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Christopher Koharski can be reached at 571-272-7230. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/MICHAEL T ROZANSKI/Primary Examiner, Art Unit 3797